102 related articles for article (PubMed ID: 9252108)
1. A prediction of DPP IV/CD26 domain structure from a physico-chemical investigation of dipeptidyl peptidase IV (CD26) from human seminal plasma.
Lambeir AM; Díaz Pereira JF; Chacón P; Vermeulen G; Heremans K; Devreese B; Van Beeumen J; De Meester I; Scharpé S
Biochim Biophys Acta; 1997 Jul; 1340(2):215-26. PubMed ID: 9252108
[TBL] [Abstract][Full Text] [Related]
2. Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5).
de Meester I; Vanhoof G; Lambeir AM; Scharpé S
J Immunol Methods; 1996 Jan; 189(1):99-105. PubMed ID: 8576585
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.
Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG
Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727
[TBL] [Abstract][Full Text] [Related]
4. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase IV from porcine seminal plasma: purification, characterization, and N-terminal amino acid sequence.
Ohkubo I; Huang K; Ochiai Y; Takagaki M; Kani K
J Biochem; 1994 Nov; 116(5):1182-6. PubMed ID: 7896751
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.
Durinx C; Lambeir AM; Bosmans E; Falmagne JB; Berghmans R; Haemers A; Scharpé S; De Meester I
Eur J Biochem; 2000 Sep; 267(17):5608-13. PubMed ID: 10951221
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV.
Thoma R; Löffler B; Stihle M; Huber W; Ruf A; Hennig M
Structure; 2003 Aug; 11(8):947-59. PubMed ID: 12906826
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase IV from human serum: purification, characterization, and N-terminal amino acid sequence.
Iwaki-Egawa S; Watanabe Y; Kikuya Y; Fujimoto Y
J Biochem; 1998 Aug; 124(2):428-33. PubMed ID: 9685737
[TBL] [Abstract][Full Text] [Related]
9. Further characterization of DPP IV-beta, a novel cell surface expressed protein with dipeptidyl peptidase activity.
Blanco J; Jacotot E; Callebaut C; Krust B; Hovanessian AG
Adv Exp Med Biol; 1997; 421():193-9. PubMed ID: 9330697
[TBL] [Abstract][Full Text] [Related]
10. Clustered charged amino acids of human adenosine deaminase comprise a functional epitope for binding the adenosine deaminase complexing protein CD26/dipeptidyl peptidase IV.
Richard E; Alam SM; Arredondo-Vega FX; Patel DD; Hershfield MS
J Biol Chem; 2002 May; 277(22):19720-6. PubMed ID: 11901152
[TBL] [Abstract][Full Text] [Related]
11. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain?
Iwaki-Egawa S; Watanabe Y; Fujimoto Y
Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235
[TBL] [Abstract][Full Text] [Related]
12. Reduced cell surface expression of a mutated dipeptidyl peptidase IV (DPP IV/CD26) correlates with the generation of a beta strand in its C-terminal domain.
David F; Baricault L; Sapin C; Gallet X; Marguet D; Thomas-Soumarmon A; Trugnan G
Biochem Biophys Res Commun; 1996 May; 222(3):833-8. PubMed ID: 8651931
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface.
Weihofen WA; Liu J; Reutter W; Saenger W; Fan H
J Biol Chem; 2004 Oct; 279(41):43330-5. PubMed ID: 15213224
[TBL] [Abstract][Full Text] [Related]
14. The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding.
Smith RE; Talhouk JW; Brown EE; Edgar SE
AIDS Res Hum Retroviruses; 1998 Jul; 14(10):851-68. PubMed ID: 9671214
[TBL] [Abstract][Full Text] [Related]
15. Identification of dipeptidyl peptidase IV as the antigen of a monoclonal anti-prostasome antibody.
Schrimpf SP; Hellman U; Carlsson L; Larsson A; Ronquist G; Nilsson BO
Prostate; 1999 Jan; 38(1):35-9. PubMed ID: 9973107
[TBL] [Abstract][Full Text] [Related]
16. Structure activity relationship modelling of milk protein-derived peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activity.
Nongonierma AB; FitzGerald RJ
Peptides; 2016 May; 79():1-7. PubMed ID: 26988873
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases.
Cuchacovich M; Gatica H; Pizzo SV; Gonzalez-Gronow M
Clin Exp Rheumatol; 2001; 19(6):673-80. PubMed ID: 11791639
[TBL] [Abstract][Full Text] [Related]
18. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).
Balzarini J; Andersson E; Schols D; Proost P; Van Damme J; Svennerholm B; Horal P; Vahlne A
Int J Biochem Cell Biol; 2004 Sep; 36(9):1848-59. PubMed ID: 15183349
[TBL] [Abstract][Full Text] [Related]
19. In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors.
Nongonierma AB; Mooney C; Shields DC; FitzGerald RJ
Peptides; 2014 Jul; 57():43-51. PubMed ID: 24793774
[TBL] [Abstract][Full Text] [Related]
20. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.
Hühn J; Olek S; Fleischer B; von Bonin A
Cell Immunol; 1999 Feb; 192(1):33-40. PubMed ID: 10066344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
